Show simple item record

dc.contributor.authorBlomberg, M
dc.contributor.authorHe, S
dc.contributor.authorHarwood, C
dc.contributor.authorArron, S
dc.contributor.authorDemehri, S
dc.contributor.authorGreen, Adèle C
dc.contributor.authorAsgari, M
dc.date.accessioned2017-11-22T20:55:43Z
dc.date.available2017-11-22T20:55:43Z
dc.date.issued2017-10-30
dc.identifier.citationResearch gaps in the management and prevention of cutaneous squamous cell carcinoma in organ transplant recipients. 2017, Br J Dermatolen
dc.identifier.issn1365-2133
dc.identifier.pmid29086412
dc.identifier.doi10.1111/bjd.15950
dc.identifier.urihttp://hdl.handle.net/10541/620660
dc.description.abstractAlthough tremendous progress has been made in recent years in skin cancer care for organ transplant recipients, significant gaps remain in data-driven clinical guidelines, particularly for the treatment and prevention of cutaneous squamous cell carcinoma (cSCC), the most common malignancy among this population. In this review, we aim to summarize current knowledge around the management of cSCC and highlight the most significant gaps in knowledge that continue to pose challenges in the delivery of skin cancer care for organ transplant recipients. We suggest future directions for research that will bridge existing gaps and establish evidence-driven guidelines for primary prevention, screening and treatment of cSCC in this high-risk patient population.
dc.language.isoenen
dc.rightsArchived with thanks to The British journal of dermatologyen
dc.titleResearch gaps in the management and prevention of cutaneous squamous cell carcinoma in organ transplant recipients.en
dc.typeArticleen
dc.contributor.departmentDepartment of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, U.S.Aen
dc.identifier.journalThe British Journal of Dermatologyen
html.description.abstractAlthough tremendous progress has been made in recent years in skin cancer care for organ transplant recipients, significant gaps remain in data-driven clinical guidelines, particularly for the treatment and prevention of cutaneous squamous cell carcinoma (cSCC), the most common malignancy among this population. In this review, we aim to summarize current knowledge around the management of cSCC and highlight the most significant gaps in knowledge that continue to pose challenges in the delivery of skin cancer care for organ transplant recipients. We suggest future directions for research that will bridge existing gaps and establish evidence-driven guidelines for primary prevention, screening and treatment of cSCC in this high-risk patient population.


This item appears in the following Collection(s)

Show simple item record